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DOI 10.1186/s10194-017-0724-3RESEARCH ARTICLE Open AccessSimulated airplane headache: a proxy
towards identification of underlying
mechanisms
Sebastian Bao Dinh Bui†, Torben Petersen†, Jeppe Nørgaard Poulsen and Parisa Gazerani*Abstract
Background: Airplane Headache (AH) occurs during flights and often appears as an intense, short lasting headache
during take-off or landing. Reports are limited on pathological mechanisms underlying the occurrence of this headache.
Proper diagnosis and treatments would benefit from identification of potential pathways involved in AH pathogenesis.
This study aimed at providing a simulated airplane headache condition as a proxy towards identification of its
underlying mechanisms.
Methods: Fourteen participants including 7 volunteers suffering from AH and 7 healthy matched controls were
recruited after meeting the diagnostic and safety criteria based on an approved study protocol. Simulation of AH was
achieved by entering a pressure chamber with similar characteristics of an airplane flight. Selected potential biomarkers
including salivary prostaglandin E2 (PGE2), cortisol, facial thermo-images, blood pressure, pulse, and saturation pulse
oxygen (SPO) were defined and values were collected before, during and after flight simulation in the pressure
chamber. Salivary samples were analyzed with ELISA techniques, while data analysis and statistical tests were handled
with SPSS version 22.0.
Results: All participants in the AH-group experienced a headache attack similar to AH experience during flight. The
non-AH-group did not experience any headaches. Our data showed that the values for PGE2, cortisol and SPO were
significantly different in the AH-group in comparison with the non-AH-group during the flight simulation in the
pressure chamber.
Conclusion: The pressure chamber proved useful not only to provoke AH-like attack but also to study potential
biomarkers for AH in this study. PGE2, and cortisol levels together with SPO presented dysregulation during the
simulated AH-attack in affected individuals compared with healthy controls. Based on these findings we propose to
use pressure chamber as a model to induce AH, and thus assess new potential biomarkers for AH in future studies.
Keywords: Simulated airplane flight, Pressure chamber, Airplane headache, Cortisol, Prostaglandin E2, Biomarker, Pulse,
Blood pressure, Thermo imagining, Saturation pulse oxygenBackground
Airplane Headache (AH) occurs in a subset of general
population during flights. It appears as an intense short
lasting headache more frequently during take-off or land-
ing [1–7]. The exact mechanism (s) underlying AH
remains unclear; but, it has been suggested as a headache
with a multifactorial pathogenesis. Current diagnosis is* Correspondence: gazerani@hst.aau.dk
†Equal contributors
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reproduction in any medium, provided you giv
the Creative Commons license, and indicate ifbased on classification of headaches set by the Inter-
national Headache Society (IHS) [1]. Some studies have
attempted to reveal AH mechanisms through various tests
including blood sampling and identification of potential
abnormalities [8, 9]. Collectively, abnormal findings have
not been detected in those who suffer from AH compared
with those who do not [8, 9]. Perhaps it is because
AH in nature is a short-lasting headache that is com-
monly terminated after the flight period is over and
most of the investigations have been done outside the
occurrence of the headache episode. Hence, furtheris distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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suitable to study AH mechanisms. One assumption is that
AH might be caused by a rapidly changing cabin-pressure,
as it is seen during take-off and landing phases [2, 8, 10].
Shifting of cabin-pressure from low to high and reverse, is
proposed to induce barotrauma within nasal sinuses or
vasodilation in the cerebral arteries, which in turn can trig-
ger AH [3, 10]. Currently, non-steroidal anti-inflammatory
drugs (NSAIDs), such as ibuprofen or naproxen, are taken
for AH, which suggests a possible contribution of an
inflammatory state. Therefore, we have chosen to study
some biomarkers in relation to pressure changes and
development of transient inflammatory state and vasodila-
tory components that may occur in AH.
Hypobaric pressure is believed to trigger vasodilation
due to a decrease in the atmospheric oxygen concentra-
tion that can cause a headache. This mechanism has
been proposed for those individuals who suffer from
High Altitude Headache (HAH) [11]. It has been sug-
gested that HAH is a risk factor for AH [2]. HAH is de-
fined by IHS as a headache that develops after ascent to
altitudes above 2500 m and resolves within 24 h after
descent to below 2500 m [1]. The pain intensity is mild
or moderate and the headache is aggravated by e.g.,
movement, straining or bending. The characteristics of
HAH imply that it is different from AH. It should be
noted that AH also can occur at ascending phase. Even
though HAH and AH are separate headaches, both
headaches are classified under the same category;”10.1
Headache attributed to hypoxia and/or hypercapnia” by
IHS [1]. It is known that hypoxia occurs during flight
travels and elevated altitudes due to the changes in the
atmospheric pressure [12, 13]. It is therefore interesting
to examine if there is a potential relationship between
these two types of headaches. If AH and HAH share a
common mechanism, changes in cabin pressure might
alter saturation pulse oxygen (SPO) and contribute in
development of AH.
In addition, vascular input has been shown to play an
important role in generation of headaches [14–18].
Vasomotor and blood flow changes due to cabin pres-
sure changes during flight might trigger AH. One of the
known vasodilators of cerebral arteries is prostaglandin
E2 (PGE2) [14, 19]. PGE2 is produced in cerebral endo-
thelial cells [20] and mast cells [21] and can be released
by cabin pressure change; but, it is not known if this oc-
curs in AH. However, PGE2 has been shown to contrib-
ute in the pathophysiology of neurovascular headaches
[22]. Under experimental conditions, when PGE2 is in-
fused, it also induces headache in healthy humans that is
most likely due to activation and sensitization of sensory
afferents innervating cranial vessels [14, 23].
Anxiety, fear and mental stress are not unusual phe-
nomena among flight passengers. Previous studies havedocumented that mental stress is higher or occurs at a
higher rate in passengers with AH-attacks [2, 9, 24].
Hence, it has been suggested that stress and anxiety may
play a role in the development of AH [9]. This indicates
that susceptible individuals with AH might even be at
higher risk for developing stress before or during air-
plane travels. Flight phobia has also been suggested to
increase mental stress during flight travels [24]. Cortisol,
released at higher concentrations during stressful condi-
tions, has been proposed to play a role in development
of headaches including AH [6]. Studies have already
shown an association between cortisol levels and other
types of headaches [25]. However, the exact role of corti-
sol remains unclear in relation to AH and needs further
investigation.
To test whether pressure changes would lead to alter-
ation in serum oxygen and circulating PGE2 concentration,
and if cortisol levels might be a factor in development of
AH, this study was designed to simulate AH as a proxy to-
wards identification of underlying mechanisms. Practical
challenges for studying AH under real conditions led us to
apply an alternative model to simulate flight-associated al-
terations in healthy individuals and those who have experi-
enced AH by placing them in a pressure chamber under
fully controlled conditions. It was proposed that pressure
chamber would cause a headache with similar characteris-
tics to AH and that it would be correlated with some alter-
ations in some biomarkers such as alterations in blood
perfusion, SPO, PGE2 and cortisol concentrations.
Methods
Study population
This AH-simulated study aimed at identification of mech-
anisms that might contribute in development of AH under
a well-controlled environment. A pressure chamber
(Training Chamber Low Pressure High Altitude Six Man
Capacity, Model ATV-183, Aero-Test Equipment Co. Inc.,
Dallas, Texas, USA) was used as a proxy to simulate AH.
The pressure chamber has been expanded to accommo-
date 7 participants instead of 6; hence, the number of re-
cruited participants for each group was limited to 7. Two
groups of AH-group and non-AH-group participated in
this study. Participants were examined by the re-
searchers and a medical authority in accordance to the
AH criteria’s defined by IHS [1], in order to verify an
accurate diagnosis of AH. The average age was 24 ±
1.6 years, where 4 of the participants were males and
the remaining 10 were females. The study protocol was
approved by the local ethics committee of Region Nordjyl-
land (approval number N-20150026) and was conducted
at the Center for Flight- and Naval Medicine, Skalstrup
Airbase, Denmark. Written informed consent was ob-
tained from all participants prior the study and travel
expenses were compensated.
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above 18 years either healthy (non-AH-group) or with
AH (based on the diagnostic criteria for AH according
to IHS’ definition of AH [1]).
Individuals were excluded during screening, if they were
pregnant, frequent users of any medications including
paracetamol, triptans, having an addictive or previously
addictive drug abuse, suffering from epilepsy, asthma,
other primary headaches, migraine or any psychological
and cardiovascular diseases. The applied criteria were
maintained to ensure a high safety level for the partici-
pants and a controlled simulation of AH headache if
occurred in the pressure chamber.
No participant was allowed in stepping the pressure
chamber if a headache occurred in the trial day due to
any reason. Participants were also asked not to eat or
drink coffee, chili, nicotine, or chocolate and to avoid
brushing teeth or using mouthwash prior to the study
(see saliva assessments below). Participants were also
asked to avoid demanding exercise or energy drinks that
might had an influence on the study outcomes.
Participants were asked to rate their pain intensity on
a scale of 1–10, where 1–3 was considered as mild head-
ache, 4–7 reflected moderate headache, and 8–10 was
considered as severe headache.
Experimental setup: pressure chamber
Participants were instructed to sit in a pressure chamber,
which was located in a military airbase, Skalstrup
Airbase, Denmark. Two safety observers from the air-
base were present during the entire procedure, ensuring
that every steps proceeds safely. The chamber contained
7 seats. Participants seated in the pressure chamber for
approximately one hour to experience a simulated air-
plane flight by altering the pressure and air composition
similar to what occurs during a real flight [26]. The pres-
sure switched from the atmospheric pressure observed
at ground level, to the pressure value present at an alti-
tude of 2438 m, and returned to the ground level when
the time was over. The ascending and descending speed
were set to 457.2 m/min ≈ 0.055 bar/min. The ascending
and descending periods lasted for 5–6 min each, while
the cruising phase lasted for almost 47 min, in an alti-
tude of 2438 m to simulate closely what occurs during
a one-hour flight in the real-world condition. No ser-
vice was provided during simulation period and ear
protection was provided for all participants to filter the
noise. Eyes were kept open and no participant slept
during the trial.
Potential biomarker assessments
A selection of assessments was used at 3 allocated time
points: before (pre-simulated flight), during (during
simulated flight) and after (post-simulated flight) theexposure to the pressure chamber. Baseline assessments
were conducted within 30 min prior to entrance to the
pressure chamber. Second assessments were conducted
in the middle of the simulated flight, when the partici-
pants had been present in the chamber for 30 min, where
the maximal altitude and pressure had been achieved. The
third and final assessments were conducted within 15 min
after participants left the chamber. Saliva samples were
collected in each allocated time point for ELISA-analysis
of PGE2 and cortisol. Each sample consisted 1.5 ml
natural saliva without any stimulation. The participants
delivered the samples by continuously salivating in a small
cup, hereafter the saliva samples were transferred to plas-
tic centrifuge tubes by single use plastic pipettes. The total
amount of collected saliva for each participant was 4.5 ml.
All samples were placed in −80 °C freezer and were kept
frozen until analysis.
Blood oxygen, pulse and blood pressure were assessed
at the allocated time points. This allowed measurements
of the participants’ pulse frequency, systolic and dia-
stolic blood pressure as well as the SPO-concentration
in their blood. Blood pressure and pulse were assessed
by using a pressure cuff (BP-102 M, Hangzhou Sejoy
Electronics & Instruments Co, Hanzhou, China), while
the oxygen saturation was assessed by using a finger-
based pulse oximeter (CMS50d, Contec Medical
Systems Co, Qinhuangdao, China).
A portable compact thermo-camera (FLIR systems
E60 thermal imager, FLIR Systems, Wilsonville Oregon,
USA) was used to capture thermo-images of partici-
pants’ faces to record the average facial skin temperature
at each dedicated time point. The thermo-camera was
calibrated before use. The sensitivity of the device was
<0.05 °C. Temperatures in the waiting room and the
pressure chamber were recorded and environmental hu-
midity was also monitored. All images were transported
on a USB pen and stored in Excel 2010 (Microsoft
Corp., Seattle, WA, USA) for further analysis.
All participants were asked to report the possible
occurrence of headache and its characteristics before,
during, and after their stay in the pressure chamber.
They were all provided with a specific questionnaire for
each time point, which aimed at documenting the find-
ings, and ensuring the safety of our participants. The
participants were asked to fill out details of their current
and recent health situation, and were requested to note
any changes that might occur during their stay. While in
the chamber, participants were asked to continuously
note and rate possible symptoms related to AH, which
included pain intensity rating, duration, location of
headache, type of headache as well as stress level and
general wellbeing. These findings were then collected
and compared with the international guidelines for AH
in order to ensure matching the criteria set by IHS.
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Data handling was conducted in Excel 2010 (Microsoft
Corp., Seattle, WA, USA). All statistical tests were con-
ducted in SPSS version 22.0 (IBM Corp., Armonk, NY,
USA). All graphical illustrations were created with
GraphPad Prism version 7.00 (GraphPad Software, La
Jolla, California, USA). Data normality was assessed by
Shapiro-Wilk’s Test of Normality. A two-way repeated
measures ANOVA was performed to determine the im-
pact of simulated airplane headache on concentrations
of PGE2, cortisol, oxygen saturation, pulse and blood
pressure at dedicated time-points of pre-simulated flight,
during the simulated flight and post-simulated flight.
Level of significance was set at p < 0.05. Data are pre-
sented as mean ± SD (standard deviation).
Results
Incidence of headache during the simulated flight
Fourteen participants completed this study. Seven were
admitted to the non-AH-group, as they did not have
any experience with bouts of AH, while the remaining
seven participants were placed in the AH-group, as they
had frequently experienced bouts of AH while travel-
ling by flight.
No participants in the non-AH-group developed a
headache or any accompanying symptoms, and none
were reported stress or anxiety while in the pressure
chamber.
All seven participants of the AH-group experienced a
headache with AH characteristics in accordance with
IHS’ criteria. The majority of AH participants (43%) de-
scribed the location of their headaches as fronto-orbital.
The quality of the headache was described mainly as
stabbing (43%). The pain intensity was described as
severe (58%) or moderate (29%) (see Table 1).
Cortisol concentration
Between group comparison showed that cortisol level was
not statistically different in the non-AH-group (1.94 ±
3.15 ng/ml) compared to the AH-group (4.62 ± 2.29 ng/
ml) at pre-simulated flight (p = 0.062). However, cortisol
was significantly higher in AH-group (5.94 ± 2.03 ng/ml)Table 1 Demographic characteristics and clinical reports from the A
Subject no Gender Age (year) AH during
simulated flight?
Duration of AH
(minutes)
Int
of
1 F 22 Yes 15 4
2 F 29 Yes 20 10
3 F 23 Yes 30 8
4 F 24 Yes 20 3
5 F 25 Yes 40 7
6 M 23 Yes 40 3
7 F 51 Yes 20 8compared with non-AH-group (1.52 ± 1.16 ng/ml) during
the simulated flight (p < 0.001). No significant difference
was found for cortisol in the non-AH-group (1.19 ±
0.50 ng/ml) compared to the AH-group (2.02 ± 0.92 ng/
ml) at post-simulated flight (p = 0.053) (see Fig. 1a).
Within group comparison in the non-AH-group dem-
onstrated that cortisol did not show any alterations when
it was compared between the time points: pre-simulated
flight and during simulated flight (p = 1.00), during simu-
lated flight and post-simulated flight (p = 0.93) or pre-
simulated flight and post-simulated flight (p = 1.00) (see
Fig. 1a).
Within group comparison in the AH-group, cortisol
stayed unaltered between pre-simulated flight and dur-
ing simulated flight (p = 0.29) but it showed a significant
difference between during simulated flight and post-
simulated flight (p < 0.001) and between pre-simulated
flight and post-simulated flight (p = 0.02) (see Fig. 1a).
PGE2 concentration
Between group comparison showed that PGE2 was
not statistically different in the non-AH-group (41.43
± 6.03 pg/mL) compared to the AH-group (38.93 ±
25.55 pg/mL) at pre-simulated flight (p = 0.82). Non-
AH-group (42.13 ± 14.63 pg/mL) compared to the
AH-group (38.16 ± 9.85 pg/mL) during the simulated
flight did not show any significant difference either
(p = 0.52). However, PGE2 was statistically different in
the non-AH-group (52.28 ± 9.02 pg/mL) compared to
the AH-group (73.32 ± 16.87 pg/mL) at post-simulated
flight (p = 0.01) (see Fig. 1b).
Within group comparison in the non-AH-group, dem-
onstrated that PGE2 did not show any remarkable alter-
ations when it was compared between the time points of
pre-simulated flight and during simulated flight (p = 1.00),
or during simulated flight and post-simulated flight
(p = 0.41). However, a significant difference was found
between pre-simulated flight and post-simulated flight
(p = 0.01) (see Fig. 1b).
Within group comparison in the AH-group, showed
no statistically significant difference in PGE2 levels be-
tween pre-simulated flight and during simulated flightH participants
ensity
pain
Quality
of pain
Localization of
the headache
Stress during
simulated flight?
Anxiety during
simulated flight?
Pulsating Unilateral No Yes
Stabbing Fronto-orbital No No
Stabbing Unilateral No Yes
Jabbing Fronto-parietal No No
Pulsating Fronto-parietal No Yes
Stabbing Fronto-orbital No No
Pulsating Fronto-orbital Yes Yes
Fig. 1 Between and within group comparisons for cortisol (a), PGE2 (b) and SPO (c). SF: Simulated flight. Bars indicate SD. *: p < 0.05. **: p < 0.001
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during simulated flight and post-simulated flight (p = 0.01)
and between pre-simulated flight and post-simulated flight
(p = 0.04) (see Fig. 1b).
Saturation pulse oxygen (SPO)
Between group comparison showed that SPO was not
statistically different in the non-AH-group (97.43 ±
1.51%) compared to the AH-group (98.00 ± 1.00%) at
pre-simulated flight (p = 0.49). However, SPO was sig-
nificantly different in the non-AH-group (95.57 ± 1.81%)
compared to the AH-group (91.85 ± 2.48%) during the
simulated flight (p < 0.001). At post-simulated flight,
SPO was not statistically different between the non-AH-
group (97.57 ± 1.13%) and the AH-group (98.14 ± 1.06%)
(p = 0.095) (see Fig. 1c).
Within group comparison in the non-AH-group, indi-
cated that SPO did not show any difference when it was
compared between the time points of pre-simulated flight
and during simulated flight (p = 0.06), during simulated
flight and post-simulated flight (p = 0.07) or pre-simulated
flight and post-simulated flight (p = 1.00) (see Fig. 1c).
Within group comparison in the AH-group, SPO was
significantly different between pre-simulated flight and
during simulated flight (p < 0.001), during simulated
flight and post-simulated flight (p < 0.001), but did not
show a difference between pre-simulated flight and post-
simulated flight (p = 1.00) (see Fig. 1c).
Pulse rate
Between group comparison showed that the pulse did not
show any significant difference in the non-AH-group(70.43 ± 17.85 bpm) compared to the AH-group (74.14 ±
10.51 bpm) at pre-simulated flight (p = 0.62). No difference
was found in the non-AH-group (74.43 ± 20.64 bpm) com-
pared to the AH-group (75.00 ± 8.91 bpm) during the sim-
ulated flight, (p = 0.96), or post-simulated flight (p = 0.20)
in the non-AH-group (72.86 ± 6.23 bpm) compared to the
AH-group (67.29 ± 6.40 bpm) (see Fig. 2a).
Within group comparison in the non-AH-group, indi-
cated that the pulse did not show any significant variations
between pre-simulated flight and during simulated flight
(p = 0.74), during simulated flight and post-simulated
flight (p = 1.00), or pre-simulated flight and post-
simulated flight (p = 1.00) (see Fig. 2a).
Within group comparison in the AH-group, pre-
sented a similar observation, where pulse did not
show a significant alteration through assessment time-
points: between pre-simulated flight and during simu-
lated flight (p = 1.00), during simulated flight and
post-simulated flight (p = 1.00), or pre-simulated flight
and post-simulated flight (p = 0.93) (see Fig. 2a).
Systolic blood pressure (SBP)
Between group comparison showed that SBP was not signifi-
cantly different in the non-AH-group (133.14 ± 18.69mmHg)
compared to the AH-group (121.14 ± 11.57 mmHg) at pre-
simulated flight (p = 0.26). This was also the case when SBP
was compared between the non-AH-group (125.71 ±
12.58 mmHg) and the AH-group (123.43 ± 14.27 mmHg)
during the simulated flight (p = 0.77), and also in the
non-AH-group (126.57 ± 11.19 mmHg) compared to
the AH-group (117.00 ± 10.60 mmHg) at post-simulated
flight (p = 0.13) (see Fig. 2b).
Fig. 2 Between and within group comparisons for pulse rate (a), SBP (b), DBP (c) and facial skin temperature (FST) (d). SF: Simulated flight. Bars
indicate SD.*: p < 0.05
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indicated that SBP did not show any significant vari-
ations when the comparisons were performed be-
tween pre-simulated flight and during simulated
flight (p = 0.78), during simulated flight and post-
simulated flight (p = 1.00), or pre-simulated flight and
post-simulated flight (p = 1.00) (see Fig. 2b).
Within group comparison in the AH-group, also indi-
cated similar findings. SBP did not vary significantly
when comparisons performed between pre-simulated
flight and during simulated flight (p = 0.50), during
simulated flight and post-simulated flight (p = 1.00), or
pre-simulated flight and post-simulated flight (p = 1.00)
(see Fig. 2b).
Diastolic blood pressure (DBP)
Between group comparison showed that DBP was not
different in the non-AH-group (81.14 ± 3.72 mmHg)
compared to the AH-group (73.00 ± 6.98 mmHg) at
pre-simulated flight (p = 0.69), nor was it different in
the non-AH-group (77.00 ± 10.86 mmHg) compared to
the AH-group (78.00 ± 8.66 mmHg) during the
simulated flight (p = 0.86), or in the non-AH-group
(77.43 ± 9.40 mmHg) compared to the AH-group
(72.71 ± 9.39 mmHg) at post-simulated flight (p = 0.34)
(see Fig. 2c).
Within group comparison in the non-AH-group, pre-
sented that DBP did not show a variation between the
assessments’ time-points: pre-simulated flight versus
during simulated flight (p = 1.00), during simulated flight
and post-simulated flight (p = 1.00), or pre-simulated
flight and post-simulated flight (p = 1.00) (see Fig. 2c).
Within group comparison in the AH-group showed no
significant change in DBP when comparisons wereperformed between pre-simulated flight and during
simulated flight (p = 0.15), during simulated flight and
post-simulated flight (p = 0.12), or pre-simulated flight
and post-simulated flight (p = 1.00) (see Fig. 2c).
Facial skin temperature
Between group comparison showed that the average
facial skin temperature was not statistically different be-
tween the non-AH-group (34.97 ± 0.24 °C) and the AH-
group (35.31 ± 0.30 °C) at pre-simulated flight (p = 0.12).
The facial skin temperature did not show any significant
difference between the non-AH-group (35.10 ± 0.14 °C)
and the AH-group (35.37 ± 0.52 °C) during the simulated
flight (p = 0.19), or at post-simulated flight (p = 0.33),
where non-AH-group (34.36 ± 0.53 °C) compared with the
AH-group (35.30 ± 0.42 °C), (see Fig. 2d).
Within group comparison in the non-AH-group,
indicated that the facial skin temperature did not show
any significant difference between pre-simulated flight and
during simulated flight (p = 1.00), during simulated flight
and post-simulated flight (p = 1.00), or pre-simulated flight
and post-simulated flight (p = 1.00) (see Fig. 2d).
Within group comparison in the AH-group, also
presented that no significant alteration in the facial
skin temperature occurred when it was compared be-
tween pre-simulated flight and during simulated flight
(p = 1.00), during simulated flight and post-simulated
flight (p = 1.00), or pre-simulated flight and post-
simulated flight (p = 1.00) (see Fig. 2d).
Discussion
This study is the first of its kind to simulate the condi-
tions of a real flight in order to allow investigating of
possible mechanisms underlying AH. Findings from our
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the conditions applied here could resemble those seen
during real flight in an airplane. All participants in the
AH-group experienced a headache under simulated con-
dition suggesting that the model works. Other features
of AH were also in accordance with AH symptoms often
reported during a real flight (see Table 2). The real AH
intensity is often described as severe (for example 8.8/10
[6]), while it was rated in average as 6.1/10 under
present simulation study. It should be noted that 3 out
of 7 in the AH-group rated their headache intensity as
3-4/10 and the rest rated it as 7 or above. In the study
by Mainardi et al. [6] up to 85% of AH-patients de-
scribed their pain as severe. Therefore, it is not unlikely
that AH also appears with lower pain intensity (15%).
Potentially, conditions of the simulated flight such as
time, cruising altitude, and speed in the current study
have also contributed in some variances in pain intensity
when compared with real flights. The duration of our
simulated flight was only one hour due to the safety con-
siderations and regulations applied to the use of the
pressure chamber. Regardless of flight length, or altitude,
AH often lasts less than 30 min [1, 6]. In some cases, a
milder second phase of headache could also occur after
the severe pain is disappeared and could last for several
hours. These patients represent a subgroup of AH [8].
Cortisol
The concentration of cortisol was elevated during the
simulated flight for the AH-group, whereas it dropped
for all members of the non-AH-group during the stay in
the pressure chamber. This is somewhat in accordance
to the results from the study by Simeoni et al. [27], who
claimed that the salivary cortisol level elevated signifi-
cantly in their healthy participants in a simulated flight.
The increase in the cortisol level for these participants
was particularly high, which is believed to be due to the
fact that the simulated flight reached an altitude of 7620
m, which induced hypoxia. The participants were di-
vided into two groups. One group had the oxygen masks
on during the simulated flight, whereas the other groupTable 2 Clinical characteristics of real-time AH (n = 75)
compared with simulated AH
Characteristics Real-time AH [6] Simulated AH
Number of subjects 75 7
Onset of AH Mainly at landing Descending phase
Duration of AH 10-30 min 26 mina
Intensity of pain 8.8/10 6.1/10a
Quality of pain Stabbing, pulsating Stabbing, pulsating
Localization Fronto-orbital, unilateral Fronto-orbital, unilateral
aMean calculations of all the subjects in the AH-group (n = 7)did not wear any oxygen masks. Considering that in our
simulated flight that only reached an altitude of 2438 m,
and no one had any mask on, it could be explained as to
why the cortisol levels in our healthy participants are
not severely affected. It has previously been shown that
certain passengers that suffers from AH, have developed
anxiety at the time of flight traveling [6]. It has also been
proven that people suffering from anxiety have elevated
levels of cortisol [28]. Our simulated flight was assisted
by safety observers who could immediately stop the sim-
ulated flight in the pressure chamber if it was necessary
and this was a source of confidence for all participants.
However, our participants suffering from AH were aware
of the fact that they were about to experience a simu-
lated flight, and thus might have a risk of developing a
bout of AH in the chamber, which was reflected on ele-
vated levels of cortisol. In this group, cortisol levels are
significantly higher before and during the simulated
flight. We do note, however, that cortisol levels in both
groups are almost equal after the simulated flight, which
might suggest, that both groups are relieved to see that
the simulated flight has come to an end. Simeoni et al.
[27] has shown that the group wearing oxygen masks in
their study only experienced a slight raise in cortisol
levels during the simulated flight. It has been proven
that headache can be triggered by extended durations of
hypoxia. It could be of great interest to see if the use of
oxygen masks by passengers suffering from AH would
decrease cortisol levels, or prevent bouts of AH during
flight.
PGE2
The PGE2 levels for both the AH- and the non-AH-
groups were almost identical both before and during the
simulated flight. However, the PGE2 level was found ele-
vated in both groups after the flight, where the increase
was higher in the AH-group. This is in accordance with
Benedetti et al. [29] who showed that the PGE2 level in-
creased significantly, when participants were moved to
an altitude of 3500 m [29], where they were exposed to
hypoxia at this altitude. All participants in this study
were healthy volunteers, who experienced HAH, while
situated in an elevated position. HAH can be a risk fac-
tor for AH as it was reported in a recent study by Bui
et al. [2] . Even though HAH and AH are two separate
headaches, hypoxia might be one of the main players in
both headaches as a consequence of atmospheric pres-
sure alteration. We therefore speculate that there might
be a possible relation between HAH and AH [2]. Our
data show that the PGE2 level is increased significantly
after the simulated flight for the AH-group, which might
show a potential link with development of AH. PGE2 is
known for causing vasodilation in the cerebral arteries
and it is thought to play a major role in development of
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strated that triptans cause vasospasm in cerebral arteries
and thereby prevent AH if the drug is administered
30 min before the flight travel. It is well-known that
vasodilation of the cerebral arteries occurs during a
migraine attack and that triptians are effective in acute
migraine [30, 31]. At least in part, based on effectiveness
of triptans, vasodilation of the cerebral arteries might be
one of the potential causes of AH [2, 10]. An interesting
finding by Benedetti et al. [29], was that the use of oxy-
gen masks decreased the PGE2 level as well as the inten-
sity of the HAH. Due to the low atmospheric pressure in
the airplane, the body would absorb less oxygen, where
hypoxia can lead to headache [2, 32, 33]. It remains
uncertain whether hypoxia is associated with AH or not,
but it would be interesting to examine if an increase in
cabin oxygen levels or use of oxygen masks can decrease
the PGE2 level and consequently prevent AH. Another
possible way of preventing AH, might be by aid of EP4
receptor antagonist, BGC20-1531. It has been shown
that elevated levels of PGE2 up-regulate EP4-receptors,
which has been suggested as a target for pain treatment
[34]. It might be of great interest to see if BGC20-1531
can be used in the future to prevent AH.
SPO
The average SPO for the healthy participants was found
decreased in both groups during the simulated flight in
the pressure chamber. A previous study has shown that
the SPO decreases during flight [28]. A total of 84
healthy participants were examined in that study. The
SPO decreased on an average from 97% to 95% in 46%
of the population during a flight lasting at least for an
hour. Despite the fact that our population only consists
of 14 participants, our data indicate that the SPO is dif-
ferent for healthy participants compared to participants
suffering from AH. The SPO for our healthy participants
decreased gradually from 97.57 ± 1.13% to 95.57 ± 1.81%,
which is in accordance with the results by Humphreys
et al. [28]. The drop was significant for the AH-group,
where the saturation decreased from 98.00 ± 1.00% to
91.85 ± 2.48%. The decreased SPO for both groups might
be the result of the low atmospheric pressure inside the
pressure chamber. It has been shown that the cabin
pressure decreases with 8 hPa for every increasing 300
m, until it stabilizes at 846 hPa for the remaining dur-
ation of the flight at an altitude of 2500 m [35]. It has
been proposed that lower atmospheric pressure can lead
to a headache due to hypoxia [11]. As compensation,
human body would absorb a lesser amount of oxygen as
pressure drops. Our data also indicate that the average
SPO was elevated after the participants left the pressure
chamber. It remains unclear whether the AH-group is
more sensitive to the changes in the atmospheric pressure,and whether or not the low saturation alone can trigger a
headache with AH features in this group. If this is the
case, it would be interesting to see if an increased oxygen
concentration in the cabin could alter the outcome.
Pulse, SBP and DBP
Our data indicate a gradual increase in pulse for both
groups of non-AH-group and AH-group during the
simulation trial in the pressure chamber, even though
the increase did not reach to a significant change statis-
tically. This finding is in accordance with the study by
Gardiner et al. [36] who examined the effect of altitude
on blood pressure and pulse in healthy participants. The
participants were elevated to an altitude of 1828 m,
which caused a decrease in blood pressure and an in-
crease in pulse. Another study by Bian et al. [37] has also
measured pulse and blood pressure for participants with
HAH during a flight at the altitude of 3500 m, where
they showed an increased blood pressure and pulse.
However, the increased blood pressure was not signifi-
cantly correlated with HAH. An increased pulse is a nor-
mal physiological compensation in human body, when
the atmospheric pressure is low. SBP and BDP for the
non-AH-group indicated a decrease during the flight,
which to some extent correlates with the results by
Gardiner et al. [36]. The SBP and BDP for the AH-group
increased gradually during the simulated flight, which
was similar to the study by Bian et al. [37]. It is known
that healthy participants can compensate changing pres-
sure by lowering the arterial blood pressure [36]. It
remains unclear however, if the gradual elevation of
blood pressure and pulse frequency would play a role in
the development of HAH, and thereby in AH, which re-
quires further studies. The study by Bian et al. [37] indi-
cates that a significant elevated pulse can trigger a bout
of HAH. A non-significant increased pulse was observed
in our AH-group during the simulated flight, but this
gradual increasing has potentially been insufficient to
evoke an attack or might be just indicating that elevated
pulse might not be a trigger for AH. Furthermore, it has
been shown that one patient with AH had a normal
pulse and blood pressure, but it is unknown if record-
ings were performed during the flight [38]. Pulse and
blood pressure might be influenced by multiple con-
founding factors and this point should definitely be
considered when interpreting data.
Facial skin temperature
We measured facial skin temperature around the nose,
sinuses and the temporal areas, to record if any alter-
ation would occur. Studies have shown that the body
temperature is slightly elevated in higher altitudes [39].
We expected to see skin temperature alterations in the
pressure chamber. An insignificant tendency was seen,
Fig. 3 Proposed mechanisms underlying development of AH.
Berilgen et al. [7] suggest that AH results from local inflammation
caused by sinus barotrauma due to changes in the atmospheric
pressure during the landing. The first degree of sinus barotrauma
[41] is a short lasting discomfort with almost no anatomical changes
in the sinuses and can be considered as a potential player in AH.
Most passengers sense pressure changes during landing and gas
trapping in the sinuses often occurs that can contribute in sinus
barotrauma and a transient local inflammation. Since we identified that
PGE2, an inflammation mediator, was higher in AH-group and SPO was
lower, we suggest that a mild hypoxia may occur during a flight travel
that may lead to reflective but perhaps mild hyperventilation. Hyper-
ventilation can result in decreasing levels of
carbon dioxide (CO2) and elevated blood pH [42]. As a response to the
decreased CO2, vasodilation may occur [42]. Vasodilation in the
cerebral arteries as a reaction to local inflammation or hypoxia can
theoretically lead to development of AH. This hypothesis should be
examined. Furthermore, interrelationship between anxiety, stress and
other environmental and internal subjective factors linked with AH
should also be investigated thoroughly to approve or falsify the
theoretical model presented here
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the AH-group compared to the non-AH-group during
simulation in the chamber. The study by Drummond
et al. [40] has examined the facial temperature among
migraine patients and healthy participants. Their results
showed that the facial temperature in the orbital region
was significantly higher among migraine patients during
a migraine attack compared to healthy participants.
Vasodilation of the cerebral arteries might be considered
as a potential cause of AH and migraine where both
headaches respond to triptans [2, 10]. Gradual elevation
of facial skin temperature in the AH-group, compared
with the non-AH-group in the chamber, could have been
triggered by an internal occurrence of a potential vaso-
dilation process. This needs further investigation to
identify whether it can be systemic, or regional, periph-
eral or central or both and to what extent. It should benoted that the participants wore ear protection during
their stay in the chamber, which interfered with the
proper measurement of the average temperature on
facial region. Had the participants been able to remove
the earmuffs (not possible due to need for communica-
tion/extreme noise), then the average temperature would
presumably have been recorded accurately. However, the
average temperature between the two groups and
between the three time-slots did not show any signifi-
cant alterations. It is plausible that temperature changes
could be relevant. A super sensitive technique or proper
preparations might yield a different outcome.
In summary, several mechanisms have been postulated
to explain the alterations seen in AH. Fig. 3 presents
proposed mechanisms underlying development of AH as
described here based on present findings and other cited
studies.
Conclusion
The present study showed a significant difference in the
values of PGE2, cortisol and SPO during an AH-attack
compared with healthy participants. These biomarkers
can attribute to a better understanding of the underlying
mechanisms in AH. The pressure chamber succeeded in
inducing an AH-like attack in the AH-group, which gives
rise to the possibility of using the pressure chamber as a
model to simulate AH on the ground and thereby facilitat-
ing assessment of other potential biomarkers or further
AH investigations in general.
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